Exact Mass: 648.4965

Exact Mass Matches: 648.4965

Found 54 metabolites which its exact mass value is equals to given mass value 648.4965, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

Uvaricin

SCHEMBL5881205

C39H68O7 (648.4965)


   

DG(16:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

(2S)-1-(Hexadecanoyloxy)-3-hydroxypropan-2-yl (5R,6Z,8E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C39H68O7 (648.4965)


DG(16:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/16:0/0:0)

(2S)-2-(hexadecanoyloxy)-3-hydroxypropyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

C39H68O7 (648.4965)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(16:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

(2R)-3-(hexadecanoyloxy)-2-hydroxypropyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

C39H68O7 (648.4965)


DG(16:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/16:0)

(2S)-3-(Hexadecanoyloxy)-2-hydroxypropyl (5S,6Z,8E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C39H68O7 (648.4965)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(16:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

(2S)-1-(Hexadecanoyloxy)-3-hydroxypropan-2-yl (5S,8Z,11Z,13E,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C39H68O7 (648.4965)


DG(16:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/16:0/0:0)

(2S)-2-(Hexadecanoyloxy)-3-hydroxypropyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C39H68O7 (648.4965)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(16:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

(2R)-3-(Hexadecanoyloxy)-2-hydroxypropyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C39H68O7 (648.4965)


DG(16:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/16:0)

(2S)-3-(Hexadecanoyloxy)-2-hydroxypropyl (5R,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C39H68O7 (648.4965)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(16:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

(2S)-1-(Hexadecanoyloxy)-3-hydroxypropan-2-yl (5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C39H68O7 (648.4965)


DG(16:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/16:0/0:0)

(2S)-2-(Hexadecanoyloxy)-3-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C39H68O7 (648.4965)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(16:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

(2R)-3-(Hexadecanoyloxy)-2-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C39H68O7 (648.4965)


DG(16:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/16:0)

(2S)-3-(Hexadecanoyloxy)-2-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C39H68O7 (648.4965)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-16:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

(2S)-1-Hydroxy-3-[(14-methylpentadecanoyl)oxy]propan-2-yl (5R,6Z,8E,10E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C39H68O7 (648.4965)


DG(i-16:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-16:0/0:0)

(2S)-3-Hydroxy-2-[(14-methylpentadecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C39H68O7 (648.4965)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-16:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

(2R)-2-Hydroxy-3-[(14-methylpentadecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C39H68O7 (648.4965)


DG(i-16:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-16:0)

(2S)-2-Hydroxy-3-[(14-methylpentadecanoyl)oxy]propyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C39H68O7 (648.4965)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-16:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

(2S)-1-Hydroxy-3-[(14-methylpentadecanoyl)oxy]propan-2-yl (5S,6E,8Z,11Z,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C39H68O7 (648.4965)


DG(i-16:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-16:0/0:0)

(2S)-3-hydroxy-2-[(14-methylpentadecanoyl)oxy]propyl (5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C39H68O7 (648.4965)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-16:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

(2R)-2-Hydroxy-3-[(14-methylpentadecanoyl)oxy]propyl (5R,6E,8Z,11Z,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C39H68O7 (648.4965)


DG(i-16:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-16:0)

(2S)-2-Hydroxy-3-[(14-methylpentadecanoyl)oxy]propyl (5R,6E,8Z,11Z,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C39H68O7 (648.4965)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-16:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

(2S)-1-hydroxy-3-[(14-methylpentadecanoyl)oxy]propan-2-yl (5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoate

C39H68O7 (648.4965)


DG(i-16:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-16:0/0:0)

(2S)-3-hydroxy-2-[(14-methylpentadecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoate

C39H68O7 (648.4965)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-16:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

(2R)-2-Hydroxy-3-[(14-methylpentadecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C39H68O7 (648.4965)


DG(i-16:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-16:0)

(2S)-2-Hydroxy-3-[(14-methylpentadecanoyl)oxy]propyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C39H68O7 (648.4965)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

1,3-divernolin

1,3-divernolin

C39H68O7 (648.4965)


   

solamin diacetate

solamin diacetate

C39H68O7 (648.4965)


   

DG(16:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

DG(16:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C39H68O7 (648.4965)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/16:0/0:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/16:0/0:0)

C39H68O7 (648.4965)


   

DG(16:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

DG(16:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C39H68O7 (648.4965)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/16:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/16:0)

C39H68O7 (648.4965)


   

DG(16:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

DG(16:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C39H68O7 (648.4965)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/16:0/0:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/16:0/0:0)

C39H68O7 (648.4965)


   

DG(16:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

DG(16:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C39H68O7 (648.4965)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/16:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/16:0)

C39H68O7 (648.4965)


   

DG(16:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

DG(16:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C39H68O7 (648.4965)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/16:0/0:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/16:0/0:0)

C39H68O7 (648.4965)


   

DG(16:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

DG(16:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C39H68O7 (648.4965)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/16:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/16:0)

C39H68O7 (648.4965)


   

DG(i-16:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

DG(i-16:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C39H68O7 (648.4965)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-16:0/0:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/i-16:0/0:0)

C39H68O7 (648.4965)


   

DG(i-16:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

DG(i-16:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C39H68O7 (648.4965)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-16:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/i-16:0)

C39H68O7 (648.4965)


   

DG(i-16:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

DG(i-16:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C39H68O7 (648.4965)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-16:0/0:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/i-16:0/0:0)

C39H68O7 (648.4965)


   

DG(i-16:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

DG(i-16:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C39H68O7 (648.4965)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-16:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/i-16:0)

C39H68O7 (648.4965)


   

DG(i-16:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

DG(i-16:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C39H68O7 (648.4965)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-16:0/0:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/i-16:0/0:0)

C39H68O7 (648.4965)


   

DG(i-16:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

DG(i-16:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C39H68O7 (648.4965)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-16:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/i-16:0)

C39H68O7 (648.4965)


   

1-{5-[1-(acetyloxy)tridecyl]oxolan-2-yl}-13-(5-methyl-2-oxo-5h-furan-3-yl)tridecyl acetate

1-{5-[1-(acetyloxy)tridecyl]oxolan-2-yl}-13-(5-methyl-2-oxo-5h-furan-3-yl)tridecyl acetate

C39H68O7 (648.4965)


   

(1s)-1-[(2'r,5r)-5'-[(1r)-1-hydroxy-13-[(5s)-5-methyl-2-oxo-5h-furan-3-yl]tridecyl]-[2,2'-bioxolan]-5-yl]undecyl acetate

(1s)-1-[(2'r,5r)-5'-[(1r)-1-hydroxy-13-[(5s)-5-methyl-2-oxo-5h-furan-3-yl]tridecyl]-[2,2'-bioxolan]-5-yl]undecyl acetate

C39H68O7 (648.4965)


   

(1s)-1-[(2r,5s)-5-[(1s)-1-(acetyloxy)tridecyl]oxolan-2-yl]-13-[(5r)-5-methyl-2-oxo-5h-furan-3-yl]tridecyl acetate

(1s)-1-[(2r,5s)-5-[(1s)-1-(acetyloxy)tridecyl]oxolan-2-yl]-13-[(5r)-5-methyl-2-oxo-5h-furan-3-yl]tridecyl acetate

C39H68O7 (648.4965)